SCHEMBL1385116

SCHEMBL1385116

OC(CNCc1ccc(Cl)cc1)COc1cccc(-c2onc3cc(F)ccc23)c1

nearest known ligand 0.49

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.44
MEN1 O00255 6/20 0.43
KMT2A Q03164 6/20 0.43
TAAR1 Q96RJ0 1/20 0.42
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ADRB2 P07550 3/20 0.40
ADRB1 P08588 3/20 0.40
ADRB3 P13945 3/20 0.40
PIK3CG P48736 1/20 0.39
DNM1 Q05193 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1385112 1.00 NPC1 (0.44) NPC1MEN1KMT2ATAAR1MAPT
SCHEMBL1384698 0.95 NPC1 (0.49) NPC1MEN1KMT2ASMN1; SMN2ADRB2
SCHEMBL7499279 0.90 NPC1 (0.51) NPC1MEN1KMT2AMAPTMAPK1
SCHEMBL7491383 0.90 NPC1 (0.41) NPC1MEN1KMT2ASMN1; SMN2ADRB2
SCHEMBL7491393 0.90 NPC1 (0.41) NPC1MEN1KMT2ASMN1; SMN2ADRB2
SCHEMBL1380360 0.86 NPC1 (0.39) NPC1MEN1KMT2AADRB2ADRB1
SCHEMBL1380366 0.86 NPC1 (0.39) NPC1MEN1KMT2AADRB2ADRB1
SCHEMBL1384570 0.85 NPC1 (0.57) NPC1MEN1KMT2AADRB2ADRB1
SCHEMBL1384566 0.85 NPC1 (0.57) NPC1MEN1KMT2AADRB2ADRB1
SCHEMBL5361309 0.84 NPC1 (0.44) NPC1MEN1KMT2ATAAR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4806149-B2 2011-11-02 JP claimed
EP-1216244-A1 Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as D4 antagonists Aventis Pharmaceuticals Inc. (US) 2002-06-26 EP claimed
WO-2001019821-A1 BENZISOXAZOLYL-, PYRIDOISOXAZOLYL- AND BENZTHIENYL-PHENOXY DERIVATIVES USEFUL AS D4 ANTAGONISTS AVENTIS PHARMACEUTICALS INC. (US) 2001-03-22 WO claimed